產(chǎn)品基本信息
產(chǎn)品編號(hào)：B680510
產(chǎn)品名稱：8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purin
產(chǎn)品CAS：853029-57-9
規(guī)格含量：2.5g
產(chǎn)品價(jià)格：面議
聯(lián)系我們:
產(chǎn)品詳細(xì)介紹
標(biāo)準(zhǔn)品編號(hào):
B680510
名稱:
8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione
別名:
1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine
CAS號(hào):
853029-57-9
分子式:
C??H??BrN?O?
外觀:
白色至淡黃色固體
熔點(diǎn):
>255°C (dec.)
分子量:
453.29
儲(chǔ)存:
Amber Vial, -20°C Freezer, Under inert atmosphere
溶解度:
DMSO (Slightly, Heated), Methanol (Slightly, Heated, Sonicated)
類別:
Building Blocks; Miscellaneous;
應(yīng)用:
8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione is an intermediate used to prepare selective inhibitors of dipeptidyl peptidase 4 (DPP4) for potential use in the treatment of type 2 diabetes.
參考文獻(xiàn)
Sutton, J., et al.: Bioorg. Med. Chem. Lett., 22, 1464 (2012); Lai, Z., et al.: Eur. J. Med. Chem., 83, 547 (2014)
?您的位置：![8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purin](/images/defaultpic.gif "8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purin")
